Hirschprung's Disease
5
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Comparative Research Between Swenson and Soave Operations for Pediatric Patients Who Have Hirschsprung Disease
Babies With Enterocolitis - A Study of Faecal Calprotectin in Hirschsprung Disease (The BEACH Study)
Transanal Versus Laparoscopic-assisted Transanal Through in the Management of Hirschsprung's Disease
Non-invasive Sacral Nerve Stimulation in Children and Adolescents With Chronic Constipation
Evaluating the Alimentary and Respiratory Tracts in Health and Disease (EARTH) Research Program.